(CGGR) Capital Growth - Ratings and Ratios
Common Stocks, Growth Companies, Large Cap Stocks
Description: CGGR Capital Growth
The Capital Group Growth ETF (CGGR) is an actively managed exchange-traded fund that focuses on investing in companies with high growth potential. The funds investment strategy is centered around identifying attractively valued companies that are expected to provide long-term investment opportunities. With a non-diversified portfolio, the fund is willing to concentrate its investments in a smaller number of securities, which can potentially lead to higher returns, but also increases the risk.
From a quantitative perspective, key performance indicators (KPIs) such as the funds expense ratio, tracking error, and Sharpe ratio can be used to evaluate its performance. Given its Large Growth category, a comparison with peers on metrics like price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, and return on equity (ROE) can provide insights into the funds valuation and profitability. Additionally, analyzing the funds sector allocation and stock holdings can help identify areas of concentration and potential risks.
The funds investment advisers professional judgment plays a crucial role in making investment decisions, and their ability to identify companies with superior growth prospects is critical to the funds success. With up to 25% of its assets invested in non-US issuers, the fund also provides exposure to international markets, which can help diversify the portfolio and potentially increase returns. Key metrics to monitor include the funds assets under management (AUM), currently at $13.78 billion, and its trading liquidity, to ensure that it can efficiently execute trades.
To further evaluate CGGRs performance, one can examine its alpha, beta, and information ratio to assess its risk-adjusted returns relative to its benchmark. Moreover, analyzing the funds holdings turnover rate and average market capitalization can provide insights into its investment style and potential risks. By combining these KPIs with the funds underlying holdings and sector allocation, investors can gain a more comprehensive understanding of CGGRs investment profile and potential opportunities.
Additional Sources for CGGR ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CGGR ETF Overview
Market Cap in USD | 14,402m |
Category | Large Growth |
TER | 0.39% |
IPO / Inception | 2022-02-22 |
CGGR ETF Ratings
Growth Rating | 66.0 |
Fundamental | - |
Dividend Rating | 51.0 |
Rel. Strength | 5.53 |
Analysts | - |
Fair Price Momentum | 39.14 USD |
Fair Price DCF | - |
CGGR Dividends
Dividend Yield 12m | 0.17% |
Yield on Cost 5y | 0.28% |
Annual Growth 5y | 22.11% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CGGR Growth Ratios
Growth Correlation 3m | 98% |
Growth Correlation 12m | 61.1% |
Growth Correlation 5y | 90.9% |
CAGR 5y | 18.16% |
CAGR/Max DD 5y | 0.63 |
Sharpe Ratio 12m | 1.66 |
Alpha | 8.77 |
Beta | 1.194 |
Volatility | 12.03% |
Current Volume | 3542k |
Average Volume 20d | 2598.9k |
Stop Loss | 40.5 (-2.9%) |
As of August 01, 2025, the stock is trading at USD 41.73 with a total of 3,542,047 shares traded.
Over the past week, the price has changed by +0.63%, over one month by +2.66%, over three months by +19.78% and over the past year by +27.28%.
Yes. Based on ValueRay's Analyses, Capital Growth (NYSE ARCA:CGGR) is currently (August 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.99 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CGGR is around 39.14 USD . This means that CGGR is currently overvalued and has a potential downside of -6.21%.
Capital Growth has no consensus analysts rating.
According to our own proprietary Forecast Model, CGGR Capital Growth will be worth about 47 in August 2026. The stock is currently trading at 41.73. This means that the stock has a potential upside of +12.56%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 47 | 12.6% |